Upstate Active Clinical Trials
Study Title:A Randomized Phase III Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
What is the purpose of the study?Treatment study to look at how well caspofungin works compared to fluconazole in preventing invasive fungal infections in patients with acute myeloid leukemia who are undergoing chemotherapy.
Upstate Institutional Review Board (IRB) Number:232784
Patient Age Group:Children
Principal Investigator:Karol H Kerr, MD
Who can I contact for more information?
Name: Beatriz Kovar